Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2019

Every FDA drug recall initiated in 2019, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,788 recalls, newest first.

Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 69842-871-30 D-0173-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 30142-505-34 D-0172-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 49035-404-61 D-0171-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. NDC 0363-0010-34 D-0170-2020
Class II · Moderate risk

Ranitidine Tablets

CGMP Deviations: Presence of NDMA impurity detected in product.

Completed Nitrosamine impurity Dr. Reddy's Laboratories, Inc. D-0169-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-9 D-0299-2020
Class II · Moderate risk

Ibuprofen Oral Suspension USP

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Terminated Particulate / foreign matter Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1385-8 D-0298-2020
Class III · Low risk

Testosterone Cypionate Injection

Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials

Terminated Labeling / mix-up Arbor Pharmaceuticals Inc. NDC 52536-625-01 D-0167-2020
Class II · Moderate risk

Estradiol tablets

Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.

Terminated Particulate / foreign matter Epic Pharma, LLC NDC 42806-087-01 D-0135-2020
Class III · Low risk

Benazepril HCl Tablets

Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle

Terminated Particulate / foreign matter Amneal Pharmaceuticals, Inc. NDC 65162-754-10 D-0134-2020
Class III · Low risk

Ranitidine Tablets USP

CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.

Ongoing cGMP deviation AuroMedics Pharma LLC NDC 55910-092-79 D-0166-2020

Recalls by year